Practice characteristics and prior authorization costs: Secondary analysis of data collected by SALT-Net in 9 central New York primary care practices

BMC Health Services Research

Volumn 14, Issue , 2014, Pages

  Epling, John W ^a,b   Mader, Emily M ^a   Morley, Christopher P ^a,b  

^a State University of New York Upstate Medical University: College of Medicine   (United States)

^b SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ECONOMICS; EPIDEMIOLOGY; GROUP PRACTICE; HUMAN; ORGANIZATION AND MANAGEMENT; PRIMARY HEALTH CARE; PRIVATE PRACTICE; REIMBURSEMENT; STATISTICS AND NUMERICAL DATA; TIME; UNITED STATES;

GROUP PRACTICE; HUMANS; INSURANCE, HEALTH, REIMBURSEMENT; NEW YORK; PRIMARY HEALTH CARE; PRIVATE PRACTICE; TIME FACTORS;

EID: 84897593055     PISSN: None     EISSN: 14726963     Source Type: Journal    
DOI: 10.1186/1472-6963-14-109     Document Type: Article

References (30)

1. Pharmacy clarification of prescriptions ordered in primary care: a report from the Applied Strategies for Improving Patient Safety (ASIPS) collaborative. Hansen LB, Fernald D, Araya-Guerra R, Westfall JM, West D, Pace W, J Am Board Fam Med 2006 19 1 24 30 10.3122/jabfm.19.1.24 16492002 (Pubitemid 44046990)
2. Healthcare utilization and cost effects of prior authorization for pregabalin in commercial health plans. Margolis JM, Cao Z, Onukwugha E, Sanchez RJ, Alvir J, Joshi AV, Mullins CD, Am J Manag Care 2010 16 6 447 456 20560688
3. The Impending Collapse of Primary Care Medicine and Its Implications for the State of the Nation's Health Care: A Report from the American College of Physicians. American College of Physicians, [http://www.acponline.org/advocacy/ advocacy-in-action/state-of-the-nations-healthcare/assets/statehc06-1.pdf]. Last Accessed March 4, 2014
4. Saving primary care. Reuben DB, Am J Med 2007 120 1 99 102 10.1016/j.amjmed.2006.10.019 17208087 (Pubitemid 46026993)
5. Impact of Medicaid prior authorization requirement for COX-2 inhibitor drugs in Nebraska. Siracuse MV, Vuchetich PJ, Health Serv Res 2008 43 1 Pt 2 435 450 18199195
6. Physician activities during time out of the examination room. Gilchrist V, McCord G, Schrop SL, King BD, McCormick KF, Oprandi AM, Selius BA, Cowher M, Maheshwary R, Patel F, Shah A, Tsai B, Zaharna M, Ann Fam Med 2005 3 6 494 499 10.1370/afm.391 16338912 (Pubitemid 43154834)
7. Time spent in face-to-face patient care and work outside the examination room. Gottschalk A, Flocke SA, Ann Fam Med 2005 3 6 488 493 10.1370/afm.404 16338911 (Pubitemid 43154833)
8. How much time does it take to prescribe a new medication? Tarn DM, Paterniti DA, Kravitz RL, Heritage J, Liu H, Kim S, Wenger NS, Patient Educ Couns 2008 72 2 311 319 10.1016/j.pec.2008.02.019 18406562
9. Costs of health care administration in the United States and Canada. Woolhandler S, Campbell T, Himmelstein DU, N Engl J Med 2003 349 8 768 775 10.1056/NEJMsa022033 12930930 (Pubitemid 37010782)
10. The economic burden associated with prior authorizations in an allergist office. Bukstein DA, Cherayil GA, Gepner AD, Luskin AT, Kooistra JB, Olson RM, Allergy Asthma Proc 2006 27 2 119 122 16724629 (Pubitemid 43700861)
11. What does it cost physician practices to interact with health insurance plans? Casalino LP, Nicholson S, Gans DN, Hammons T, Morra D, Karrison T, Levinson W, Health Aff (Millwood) 2009 28 4 533 43 10.1377/hlthaff.28.4.w533 19443477
12. Peering into the black box: billing and insurance activities in a medical group. Sakowski JA, Kahn JG, Kronick RG, Newman JM, Luft HS, Health Aff (Millwood) 2009 28 4 544 54 10.1377/hlthaff.28.4.w544 19443478
13. US physician practices versus Canadians: spending nearly four times as much money interacting with payers. Morra D, Nicholson S, Levinson W, Gans DN, Casalino LP, Hammons T, Health Aff (Millwood) 2011 30 8 1443 1450 10.1377/hlthaff.2010.0893 21813866
14. Standardization of prior authorization process for medical services white paper. American Medical Association, 2011 [ http://www.ama-assn.org/resources/ doc/psa/standardization-prior-auth-whitepaper.pdf ].?Last Accessed: March 4, 2014
15. The impact of prior authorization requirements on primary care physicians' offices: report of two parallel network studies. Morley CP, Badolato DJ, Hickner J, Epling JW, J Am Board Fam Med 2013 26 1 93 95 10.3122/jabfm.2013.01.120062 23288287
16. ZIP Code RUCA Approximation. Rural Health Research Center, [ http://depts.washington.edu/uwruca/ruca-approx.php ] Last Accessed: November 25, 2013
17. Systematic review of health information exchange in primary care practices. Fontaine P, Ross SE, Zink T, Schilling LM, J Am Board Fam Med 2010 23 5 655 670 10.3122/jabfm.2010.05.090192 20823361
18. The use of electronic health records in the exam room and patient satisfaction: a systematic review. Irani JS, Middleton JL, Marfatia R, Omana ET, D'Amico F, J Am Board Fam Med 2009 22 5 553 562 10.3122/jabfm.2009.05.080259 19734402
19. Primary care's eroding earnings: is congress concerned? Laing BY, Bodenheimer T, Phillips RL Jr, Bazemore A, Bazemore A, J Fam Pract 2008 57 9 578 583 18786329
20. Modifying prescribing behaviour of angiotensin receptor blockers by selectively rescinding managerial prior authorization requirements for losartan. Kahan NR, Chinitz DP, Blackman S, Waitman D, Vardy DA, Br J Clin Pharmacol 2011 72 6 997 1001 10.1111/j.1365-2125.2011.04044.x 21689138
21. When gatekeepers meet the sentinel: the impact of a prior authorization requirement for cefuroxime on the prescribing behaviour of community-based physicians. Kahan NR, Chinitz DP, Waitman D, Kahan E, Br J Clin Pharmacol 2006 61 3 341 4 10.1111/j.1365-2125.2006.02577.x 16487229 (Pubitemid 43382635)
22. Prior authorization for biologic disease-modifying antirheumatic drugs: a description of US Medicaid programs. Fischer MA, Polinski JM, Servi AD, Agnew-Blais J, Kaci L, Solomon DH, Arthritis Rheum 2008 59 11 1611 7 10.1002/art.24191 18975371
23. Impact of Medicaid prior authorization on angiotensin-receptor blockers: can policy promote rational prescribing? Fischer MA, Choudhry NK, Winkelmayer WC, Health Aff (Millwood) 2007 26 3 800 7 10.1377/hlthaff.26.3.800 17485759
24. Impact of prior authorization on the use and costs of lipid-lowering medications among Michigan and Indiana dual enrollees in Medicaid and Medicare: results of a longitudinal, population-based study. Lu CY, Law MR, Soumerai SB, Graves AJ, LeCates RF, Zhang F, Ross-Degnan D, Adams AS, Clin Ther 2011 33 1 135 144 10.1016/j.clinthera.2011.01.012 21397779
25. Economic impact of prior authorization policies for atypical antipsychotics in the treatment of schizophrenia. Abouzaid S, Jutkowitz E, Foley KA, Pizzi LT, Kim E, Bates J, Popul Health Manag 2010 13 5 247 254 10.1089/pop.2009.0063 20879905
26. Impact of two Medicaid prior-authorization policies on antihypertensive use and costs among Michigan and Indiana residents dually enrolled in Medicaid and Medicare: results of a longitudinal, population-based study. Law MR, Lu CY, Soumerai SB, Graves AJ, LeCates RF, Zhang F, Ross-Degnan D, Adams AS, Clin Ther 2010 32 4 729 41 discussion 716 10.1016/j.clinthera.2010.04.007 20435243
27. Impact of a prior authorization for pregabalin on health plan drug expenditures. Bazalo G, Weiss RC, Joshi AV, Am J Manag Care 2010 16 5 Suppl 154 9 20586524
28. Future of family medicine project leadership committee: the future of family medicine: a collaborative project of the family medicine community. Martin JC, Avant RF, Bowman MA, Bucholtz JR, Dickinson JR, Evans KL, Green LA, Henley DE, Jones WA, Matheny SC, Nevin JE, Panther SL, Puffer JC, Roberts RG, Rodgers DV, Sherwood RA, Stange KC, Weber CW, Ann Fam Med 2004 2 Suppl 1 3 32 15080220
29. The medical home: growing evidence to support a new approach to primary care. Rosenthal TC, J Am Board Fam Med 2008 21 5 427 440 10.3122/jabfm.2008.05. 070287 18772297
30. Primary care: life in the pressure cooker. Nicoletti B, J Med Pract Manage 2008 23 6 343 344 18616000 (Pubitemid 351898494)